Finance

Lists
Why is BGLC up 5.83%?
Dive Deeper
BGLC:NASDAQ
BioNexus Gene Lab Corp
$1.27
+5.83%
(+0.070) 1D
$1.22
-4.16% (-0.053)
After hours
Closed: Oct 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BGLC...
Open
$1.25
High
$1.28
Low
$1.25
Mkt. cap
3.73M
Avg. vol.
6.21K
Volume
2.95K
52-wk high
$5.85
52-wk low
$1.07
EPS
-$1.25
Beta
-0.94
Shares outstanding
2.93M
No. of employees
19
Open
$1.25
High
$1.28
Low
$1.25
Mkt. cap
3.73M
Avg. vol.
6.21K
Volume
2.95K
52-wk high
$5.85
52-wk low
$1.07
EPS
-$1.25
Beta
-0.94
Shares outstanding
2.93M
No. of employees
19
News stories
From web sources and news partners
About BioNexus Gene Lab Corp
CEO-
Employees19
Founded2017
Headquarters-
SectorTrading company
Websitebionexusgenelab.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.54M
483.76K
22.84K
76.16K
Cost of goods sold
2.17M
487.74K
23.63K
63.17K
Cost of revenue
2.17M
487.74K
23.63K
63.17K
Research and development expenses
14.88K
11.10K
14.49K
13.67K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
997.26K
216.74K
380.40K
334.55K
Operating expense
1.15M
1.12M
562.50K
316.61K
Total operating expenses
3.31M
1.60M
586.13K
379.78K
Operating income
-769.86K
-1.12M
-563.29K
-303.62K
Other non operating income
-
1.40K
-
-
EBT including unusual items
-708.99K
-1.04M
-543.58K
-286.45K
EBT excluding unusual items
-751.37K
-1.21M
-543.58K
-286.45K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-40.41K
87.75K
-8.15K
-8.39K
Net income
-708.99K
-1.04M
-543.58K
-286.45K
Net profit margin
-27.87%
-214.18%
-2,379.72%
-376.14%
Earnings per share
-
-
-
-
Interest and investment income
24.97K
10.13K
17.18K
21.18K
Interest expense
-6.48K
-3.27K
-3.08K
-4.06K
Net interest expenses
18.49K
6.86K
14.09K
17.13K
Depreciation and amortization charges
-
-
-
-
EBITDA
-740.85K
-1.09M
-534.99K
-272.84K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps